Unheard gross margins of 95% and a $800B TAM : $GDRX
GoodRx is a free-to-use service that allows Americans to find the lowest-cost prescription drugs in their area. The company makes money by receiving a commission for every prescription order filled via its coupons, which are accepted by nearly all 70,000 pharmacies across the country.
-Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews)
-Partnership with Kroger
-Competing with TDOC with the launch of HeyDoctor
- Rising prices of pharmaceuticals and their mission is to lower the cost of healthcare
-95% Gross margin (What?!?!). 30% Operating margin.
- 75M Free cash flow.
- TAM $800 Mn
- NPS 86
- 4.6/5 Glassdoor
- Founder led
Concerns,
1. P/S of 37.1 and 201 PE. Average PE in healthcare is 24.
2. IPO hype(good for trades though)
3. 94% of top line revenue still coming in from prescription stream(concentration risk?) which grew 42% Q1.
4. Regulations
5. International expansion?
6. 4 holders own 60-65% of the company(Both good and bad)
TA,
1. Wedge breakout
2. Potential base of Cup.
3. Low volume on Pullback
Not a long term position yet. Swing trade.
Entry : break of 52
Stop loss : 49 (-7.8%)
-Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews)
-Partnership with Kroger
-Competing with TDOC with the launch of HeyDoctor
- Rising prices of pharmaceuticals and their mission is to lower the cost of healthcare
-95% Gross margin (What?!?!). 30% Operating margin.
- 75M Free cash flow.
- TAM $800 Mn
- NPS 86
- 4.6/5 Glassdoor
- Founder led
Concerns,
1. P/S of 37.1 and 201 PE. Average PE in healthcare is 24.
2. IPO hype(good for trades though)
3. 94% of top line revenue still coming in from prescription stream(concentration risk?) which grew 42% Q1.
4. Regulations
5. International expansion?
6. 4 holders own 60-65% of the company(Both good and bad)
TA,
1. Wedge breakout
2. Potential base of Cup.
3. Low volume on Pullback
Not a long term position yet. Swing trade.
Entry : break of 52
Stop loss : 49 (-7.8%)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.